Verve Therapeutics Inc (VERV)
6.37
+0.29
(+4.77%)
USD |
NASDAQ |
May 09, 16:00
6.39
+0.02
(+0.31%)
After-Hours: 20:00
Verve Therapeutics Price: 6.37 for May 9, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 6.13 | 6.725 | 6.13 | 6.37 | 1.752M |
| May 08, 2024 | 6.13 | 6.29 | 5.99 | 6.08 | 1.464M |
| May 07, 2024 | 6.46 | 6.46 | 6.04 | 6.16 | 888521.0 |
| May 06, 2024 | 6.50 | 6.725 | 6.28 | 6.41 | 812274.0 |
| May 03, 2024 | 6.43 | 7.00 | 6.28 | 6.41 | 1.395M |
| May 02, 2024 | 6.13 | 6.25 | 6.00 | 6.15 | 949617.0 |
| May 01, 2024 | 6.04 | 6.56 | 5.84 | 6.00 | 1.765M |
| Apr 30, 2024 | 6.09 | 6.315 | 5.958 | 6.01 | 1.022M |
| Apr 29, 2024 | 6.25 | 6.55 | 6.11 | 6.26 | 933216.0 |
| Apr 26, 2024 | 6.26 | 6.409 | 6.02 | 6.16 | 791566.0 |
| Apr 25, 2024 | 6.28 | 6.35 | 6.05 | 6.22 | 1.221M |
| Apr 24, 2024 | 6.87 | 6.92 | 6.525 | 6.58 | 1.004M |
| Apr 23, 2024 | 6.90 | 7.41 | 6.81 | 6.88 | 965009.0 |
| Apr 22, 2024 | 6.75 | 7.03 | 6.46 | 6.91 | 909065.0 |
| Apr 19, 2024 | 6.59 | 6.80 | 6.42 | 6.64 | 1.098M |
| Apr 18, 2024 | 6.70 | 6.86 | 6.53 | 6.66 | 1.247M |
| Apr 17, 2024 | 7.23 | 7.27 | 6.72 | 6.74 | 1.155M |
| Apr 16, 2024 | 7.15 | 7.264 | 7.03 | 7.14 | 691055.0 |
| Apr 15, 2024 | 7.73 | 7.73 | 7.13 | 7.31 | 1.369M |
| Apr 12, 2024 | 7.97 | 8.02 | 7.54 | 7.60 | 1.210M |
| Apr 11, 2024 | 8.40 | 8.40 | 7.90 | 8.07 | 1.076M |
| Apr 10, 2024 | 8.25 | 8.40 | 7.76 | 8.01 | 1.722M |
| Apr 09, 2024 | 8.43 | 8.77 | 8.37 | 8.75 | 872807.0 |
| Apr 08, 2024 | 8.75 | 8.75 | 8.24 | 8.40 | 1.035M |
| Apr 05, 2024 | 8.53 | 8.75 | 8.18 | 8.52 | 1.385M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.00
Minimum
May 01 2024
73.99
Maximum
Sep 10 2021
25.21
Average
19.87
Median
Jul 10 2023
Price Benchmarks
| Acorda Therapeutics Inc | 0.65 |
| Eli Lilly and Co | 771.55 |
| Beam Therapeutics Inc | 22.54 |
| Intellia Therapeutics Inc | 24.87 |
| Gritstone Bio Inc | 0.9728 |
Price Related Metrics
| PS Ratio | 28.80 |
| Price to Book Value | 0.9173 |
| Earnings Yield | -45.05% |
| Market Cap | 534.86M |